<scp>HPV16 E6</scp>‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study-Reference-Cited by-同舟云学术

HPV16 E6‐antibody associated risk of oropharyngeal cancer increases by calendar‐time: A nested case‐control study

Published:2023-06-08 Issue:6 Volume:153 Page:1313-1315
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Lehtinen Matti¹^ORCID,Butt Julia²^ORCID,Gray Penelope¹^ORCID,Brenner Nicole²,Eriksson Tiina³,Lehtinen Tuomas³^ORCID,Luostarinen Tapio⁴^ORCID,Schroeder Lea²,Surcel Heljä‐Marja⁵⁶,Mäkitie Antti⁷⁸,Pimenoff Ville N.¹⁵⁶^ORCID,Waterboer Tim²

Affiliation:

1. Department of Clinical Science, Intervention and Technology Karolinska Institutet Stockholm Sweden

2. Division of Infections and Cancer Epidemiology Deutsches Krebsforschungszentrum (DKFZ) Heidelberg Germany

3. Finnish Cancer Center Mid Tampere Finland

4. Finnish Cancer Registry Helsinki Finland

5. Finnish Maternity Cohort, University of Oulu Oulu Finland

6. European Scientific Infra‐structure Services (ESIS) Oulu Finland

7. Department of Otorhinolaryngology – Head and Neck Surgery, Research Program in Systems Oncology University of Helsinki and Helsinki University Hospital Helsinki Finland

8. Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology Karolinska Institutet and Karolinska University Hospital Stockholm Sweden

Funder

Center for Innovative Medicine

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34614

Reference10 articles.

1. Elimination of HPV–associated oropharyngeal cancers in Nordic countries

2. Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution

3. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014

4. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

5. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma